The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis

Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer

(2018) Youya Nakazawa et al.   Scientific Reports

Cathepsin K Controls Cortical Bone Formation by Degrading Periostin

(2017) Nicolas Bonnet et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Periostin expression contributes to cortical bone loss during unloading

(2015) Maude Gerbaix et al.   BONE

Gamma-Carboxylation and Fragmentation of Osteocalcin in Human Serum Defined by Mass Spectrometry

(2015) Douglas S. Rehder et al.   MOLECULAR & CELLULAR PROTEOMICS

Serum periostin is associated with prevalent knee osteoarthritis and disease incidence/progression in women: the OFELY study

(2015) J.C. Rousseau et al.   OSTEOARTHRITIS AND CARTILAGE

Targeting ECM Disrupts Cancer Progression

(2015) Freja A. Venning et al.   Frontiers in Oncology

Absence of Vitamin K-Dependent γ-Carboxylation in Human Periostin Extracted from Fibrotic Lung or Secreted from a Cell Line Engineered to Optimize γ-Carboxylation

(2015) Douglas S. Annis et al.   PLoS One

Periostin: A New Extracellular Regulator of Obesity-Induced Hepatosteatosis

(2014) Tiantian Wu et al.   Cell Metabolism

Serum Periostin Is Associated With Fracture Risk in Postmenopausal Women: A 7-Year Prospective Analysis of the OFELY Study

(2014) J. C. Rousseau et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments

(2014) Allan Yi Liu et al.   MATRIX BIOLOGY

Efficacy of a Cathepsin K Inhibitor in a Preclinical Model for Prevention and Treatment of Breast Cancer Bone Metastasis

(2014) L. T. Duong et al.   MOLECULAR CANCER THERAPEUTICS

Cathepsin K: a unique collagenolytic cysteine peptidase

(2013) Marko Novinec et al.   BIOLOGICAL CHEMISTRY

Proteomic Identification of Matrix Metalloproteinase Substrates in the Human Vasculature

(2012) Christin Stegemann et al.   Circulation-Cardiovascular Genetics

Anti-IL-20 Monoclonal Antibody Suppresses Breast Cancer Progression and Bone Osteolysis in Murine Models

(2012) Y.-H. Hsu et al.   JOURNAL OF IMMUNOLOGY

The multiple facets of periostin in bone metabolism

(2012) B. Merle et al.   OSTEOPOROSIS INTERNATIONAL

Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin

(2012) N. Bonnet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Consensus on the utility of bone markers in the malignant bone disease setting

(2011) Robert Coleman et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Multiplex Zymography Captures Stage-specific Activity Profiles of Cathepsins K, L, and S in Human Breast, Lung, and Cervical Cancer

(2011) Binbin Chen et al.   Journal of Translational Medicine

Interactions between cancer stem cells and their niche govern metastatic colonization

(2011) Ilaria Malanchi et al.   NATURE

Development of a New ELISA for Serum Periostin: Evaluation of Growth-Related Changes and Bisphosphonate Treatment in Mice

(2010) Sylvain Contié et al.   CALCIFIED TISSUE INTERNATIONAL

Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases

(2010) Sylvain Contié et al.   INTERNATIONAL JOURNAL OF CANCER

Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro

(2010) Patrick Garnero et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The Matricellular Protein Periostin Is Required forSostInhibition and the Anabolic Response to Mechanical Loading and Physical Activity

(2009) Nicolas Bonnet et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression

(2008) C. G. Kleer et al.   CLINICAL CANCER RESEARCH

Periostin, a Member of a Novel Family of Vitamin K-dependent Proteins, Is Expressed by Mesenchymal Stromal Cells

(2008) Daniel L. Coutu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Circulating cathepsin K and cystatin C in patients with cancer related bone disease: Clinical and therapeutic implications

(2007) Francesca M. Tumminello et al.   BIOMEDICINE & PHARMACOTHERAPY